CL2009000183A1 - Uso de nucleotidos de uridina, guanosina, citidina, timidina y adenosina en una composicion de alimento para peces para mejorar el desarrollo intestinal del pez.(divisional 2787-00). - Google Patents

Uso de nucleotidos de uridina, guanosina, citidina, timidina y adenosina en una composicion de alimento para peces para mejorar el desarrollo intestinal del pez.(divisional 2787-00).

Info

Publication number
CL2009000183A1
CL2009000183A1 CL2009000183A CL2009000183A CL2009000183A1 CL 2009000183 A1 CL2009000183 A1 CL 2009000183A1 CL 2009000183 A CL2009000183 A CL 2009000183A CL 2009000183 A CL2009000183 A CL 2009000183A CL 2009000183 A1 CL2009000183 A1 CL 2009000183A1
Authority
CL
Chile
Prior art keywords
fish
intestinal
cytidine
uridine
guanosine
Prior art date
Application number
CL2009000183A
Other languages
English (en)
Inventor
Charles Burrells
Paul David Williams
Original Assignee
Ewos Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26244146&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2009000183(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9924096.2A external-priority patent/GB9924096D0/en
Priority claimed from GB0009853A external-priority patent/GB0009853D0/en
Application filed by Ewos Ltd filed Critical Ewos Ltd
Publication of CL2009000183A1 publication Critical patent/CL2009000183A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/153—Nucleic acids; Hydrolysis products or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/13—Nucleic acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00—Food or edible material: processes, compositions, and products
    • Y10S426/805—Pet food for dog, cat, bird, or fish

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Birds (AREA)
  • Insects & Arthropods (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)

Abstract

USO DE NUCLEOTIDOS DE URIDINA GUANOSINA CITIDINA TIMIDINA Y ADENOSINA EN UNA  COMPOSICION  DE ALIMENTO PARA PECES,  QUE SIRVE PARA MEJORAR EL DESARROLLO INTESTINAL DEL PEZ,  LO QUE SE TRADUCE EN UNA MEJORA DE LA ABSORCION INTESTINAL DE ADITIVOS DIETÉTICOS EN LOS PECES.
CL2009000183A 1999-10-13 2009-01-28 Uso de nucleotidos de uridina, guanosina, citidina, timidina y adenosina en una composicion de alimento para peces para mejorar el desarrollo intestinal del pez.(divisional 2787-00). CL2009000183A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9924096.2A GB9924096D0 (en) 1999-10-13 1999-10-13 Supplement
GB0009853A GB0009853D0 (en) 2000-04-25 2000-04-25 Supplement

Publications (1)

Publication Number Publication Date
CL2009000183A1 true CL2009000183A1 (es) 2009-05-22

Family

ID=26244146

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2009000183A CL2009000183A1 (es) 1999-10-13 2009-01-28 Uso de nucleotidos de uridina, guanosina, citidina, timidina y adenosina en una composicion de alimento para peces para mejorar el desarrollo intestinal del pez.(divisional 2787-00).

Country Status (11)

Country Link
US (1) US6987095B1 (es)
EP (2) EP1220617B1 (es)
JP (1) JP2003511051A (es)
AT (1) ATE431080T1 (es)
AU (1) AU770961B2 (es)
CA (1) CA2382636C (es)
CL (1) CL2009000183A1 (es)
DE (1) DE60042211D1 (es)
NO (1) NO20021734D0 (es)
NZ (1) NZ518305A (es)
WO (1) WO2001026481A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0218932D0 (en) * 2002-08-14 2002-09-25 Zoolife Internat Ltd Composition for dietary enrichment
EP2117342B1 (en) 2007-02-08 2016-04-20 Ewos Innovation AS Feed composition for salmonids and uses thereof
CA2698051C (en) * 2007-08-29 2016-02-16 Mars, Incorporated Single-serve cat food product and methods for same
NO339169B1 (no) * 2008-04-24 2016-11-14 Chemoforma Ltd Funksjonelt fiskefôr omfattende peptidoglykan og nukleotider
JP6862541B2 (ja) * 2017-04-28 2021-04-21 国立大学法人高知大学 水棲動物用飼料
JP7471648B2 (ja) * 2020-10-27 2024-04-22 獣医医療開発株式会社 魚類用薬剤組成物および魚類用薬用飼料

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5712972A (en) 1980-06-23 1982-01-22 Takeda Chem Ind Ltd Preparation of food product containing 5"-nucleotide
JPS60126220A (ja) * 1983-12-09 1985-07-05 Otsuka Pharmaceut Factory Inc 核酸成分組成物
JPS6229530A (ja) 1985-07-31 1987-02-07 Nisshin Flour Milling Co Ltd ウナギの鰓病薬
JPH03164140A (ja) * 1989-11-21 1991-07-16 Sanyo Kokusaku Pulp Co Ltd 養魚用飼料組成物
JP2756907B2 (ja) 1993-12-28 1998-05-25 日本製紙株式会社 酵母エキス組成物及びその製造法並びにそれを含有する飼料
JPH07231755A (ja) * 1994-02-24 1995-09-05 Kohjin Co Ltd 赤色肉魚類用肉色改善飼料と赤色肉魚類の養殖方法
US5871751A (en) * 1994-10-12 1999-02-16 The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Renibacterium salmoninarum vaccine and method for its preparation
US5776490A (en) 1996-01-26 1998-07-07 The Center For Innovative Technology Complex protein-walled microcapsules containing lipid-walled microcapsules and method for producing same
EP0923312A1 (en) * 1996-04-29 1999-06-23 K.U. Leuven Research & Development Oral delivery form having a high absorption efficiency and method for making same

Also Published As

Publication number Publication date
CA2382636C (en) 2011-03-22
AU770961B2 (en) 2004-03-11
CA2382636A1 (en) 2001-04-19
EP1220617A1 (en) 2002-07-10
WO2001026481A1 (en) 2001-04-19
EP2050344A1 (en) 2009-04-22
NO20021734L (no) 2002-04-12
AU7676200A (en) 2001-04-23
ATE431080T1 (de) 2009-05-15
JP2003511051A (ja) 2003-03-25
NZ518305A (en) 2004-08-27
EP1220617B1 (en) 2009-05-13
NO20021734D0 (no) 2002-04-12
US6987095B1 (en) 2006-01-17
DE60042211D1 (de) 2009-06-25

Similar Documents

Publication Publication Date Title
CL2009000183A1 (es) Uso de nucleotidos de uridina, guanosina, citidina, timidina y adenosina en una composicion de alimento para peces para mejorar el desarrollo intestinal del pez.(divisional 2787-00).
CA2372085A1 (en) L-ribo-lna analogues
RU2227143C2 (ru) Новые бициклонуклеозидные аналоги
DE60122285D1 (de) Methonocarbacycloalkylanaloga von nucleosiden
EP0977767A4 (en) AMINOOXY-MODIFIED OLIGONUCLEOTIDES
ATE432284T1 (de) Einen starren linker enthaltende nukleotide
NZ543867A (en) Modified fluorinated nucleoside analogues
WO2003062255A3 (en) Sugar modified nucleosides as viral replication inhibitors
WO2000030629A3 (en) Method of promoting cervical and vaginal secretions
IL100298A0 (en) 3'-(2')-amino-or thiol-modified,fluorescent dye-coupled nucleosides,nucleotides and oligonucleotides,and a process for the preparation and the use thereof
DK0679657T3 (da) Nukleosider og oligonukleotider med 2'-ethergrupper
AU2890497A (en) Nucleoside derivatives with photolabile protective groups
GB2340491A (en) Carbocyclic nucleoside hemisulfate and its use in treating viral infections
GR3026166T3 (en) Conformationally locked nucleoside analogues
HUP0300219A2 (hu) L-nukleozidokat, L-nukleotidokat és analógjaikat tartalmazó készítmények és alkalmazásuk
DE69813203D1 (de) Verbesserte Primer zur AFLP Amplifizierung
DE69632830D1 (de) Rezeptor und dafür kodierendes nukleinsäuremolekül
Hirao et al. A unique unnatural base pair between a C analogue, pseudoisocytosine, and an A analogue, 6-methoxypurine, in replication
KR960701639A (ko) 심기능 회복제(heart function restorative)
Taha et al. Synthesis of some acyclonucleosides α-(pyrazolo [3, 4-d] pyrimidin-4-ylthio)-alkylamides
HK1009451A1 (en) Process for the synthesis of nucleoside analogues
Mathé et al. Synthesis and Antiviral Evaluation of 3′-Deoxy-β-L-erythro-pentofuranosyl Nucleosides of the Five Naturally Occurring Nucleic Acid Bases
Yoshimura et al. Synthesis of (2′ S)-1-(2-C-Azidomethyl-2-deoxy and 2-C-Cyanomethyl-2-deoxy-β-D-arabinofuranosyl) cytosines
Shibata et al. Guanosine triphosphate (GTP) breakdown products in Antarctic krill Euphausia superba
D’MELLO School of Agriculture, West Mains Road, Edinburgh EH9 3JG